{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:55:16Z","timestamp":1787680516506,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"DOI":"10.1007\/s00701-023-05545-2","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T08:03:02Z","timestamp":1678953782000},"page":"1615-1633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case series"],"prefix":"10.1007","volume":"165","author":[{"given":"Jos\u00e9 Pedro","family":"Lavrador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zita","family":"Reisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Sibtain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Rajwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4177-9615","authenticated-orcid":false,"given":"Asfand","family":"Baig Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeev","family":"Bhangoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyoumars","family":"Ashkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bleil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Zebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Laxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Bodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Al-Saraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"issue":"1","key":"5545_CR1","first-page":"vdab047","volume":"3","author":"A Baig Mirza","year":"2021","unstructured":"Baig Mirza A, Christodoulides I, Lavrador JP et al (2021) 5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma-a comparative cohort study of 343 patients. Neurooncol Adv 3(1):vdab047","journal-title":"Neurooncol Adv"},{"issue":"6","key":"5545_CR2","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2020.11.012","volume":"183","author":"CCL Chen","year":"2020","unstructured":"Chen CCL, Deshmukh S, Jessa S et al (2020) Histone H3.3G34-mutant interneuron progenitors co-opt PDGFRA for gliomagenesis. Cell 183(6):1617-1633.e22","journal-title":"Cell"},{"issue":"10","key":"5545_CR3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens A-C, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997\u20131003","journal-title":"N Engl J Med"},{"issue":"1","key":"5545_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12967-022-03258-1","volume":"20","author":"W Hu","year":"2022","unstructured":"Hu W, Duan H, Zhong S, Zeng J, Mou Y (2022) High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope? J Transl Med 20(1):64","journal-title":"J Transl Med"},{"issue":"2","key":"5545_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00412-015-0510-4","volume":"124","author":"S Kallappagoudar","year":"2015","unstructured":"Kallappagoudar S, Yadav RK, Lowe BR, Partridge JF (2015) Histone H3 mutations\u2013a special role for H3.3 in tumorigenesis? Chromosoma 124(2):177\u2013189","journal-title":"Chromosoma"},{"issue":"1","key":"5545_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-015-1493-1","volume":"131","author":"A Korshunov","year":"2016","unstructured":"Korshunov A, Capper D, Reuss D et al (2016) Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathol 131(1):137\u2013146","journal-title":"Acta Neuropathol"},{"issue":"1","key":"5545_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jon.12939","volume":"32","author":"R Kurokawa","year":"2022","unstructured":"Kurokawa R, Baba A, Kurokawa M, Pinarbasi ES, Makise N, Ota Y, Kim J, Srinivasan A, Moritani T (2022) Neuroimaging features of diffuse hemispheric glioma, H3 G34-mutant: a case series and systematic review. J Neuroimaging 32(1):17\u201327","journal-title":"J Neuroimaging"},{"issue":"1","key":"5545_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-016-2349-9","volume":"132","author":"J Lee","year":"2017","unstructured":"Lee J, Solomon DA, Tihan T (2017) The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children. J Neurooncol 132(1):1\u201311","journal-title":"J Neurooncol"},{"issue":"1","key":"5545_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10014-020-00378-8","volume":"38","author":"KY Lim","year":"2021","unstructured":"Lim KY, Won JK, Park C-K, Kim S-K, Choi SH, Kim T, Yun H, Park S-H (2021) H3 G34-mutant high-grade glioma. Brain Tumor Pathol 38(1):4\u201313","journal-title":"Brain Tumor Pathol"},{"issue":"6","key":"5545_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(6):803\u2013820","journal-title":"Acta Neuropathol"},{"issue":"8","key":"5545_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23(8):1231\u20131251","journal-title":"Neuro Oncol"},{"key":"5545_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050660","author":"BR Lowe","year":"2019","unstructured":"Lowe BR, Maxham LA, Hamey JJ, Wilkins MR, Partridge JF (2019) Histone H3 mutations: an updated view of their role in chromatin deregulation and cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11050660","journal-title":"Cancers (Basel)"},{"issue":"11","key":"5545_CR13","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/neuonc\/noab184","volume":"23","author":"C-HG Lucas","year":"2021","unstructured":"Lucas C-HG, Mueller S, Reddy A et al (2021) Diffuse hemispheric glioma, H3 G34-mutant: genomic landscape of a new tumor entity and prospects for targeted therapy. Neuro Oncol 23(11):1974\u20131976","journal-title":"Neuro Oncol"},{"issue":"4","key":"5545_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D et al (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(4):520-537.e5","journal-title":"Cancer Cell"},{"issue":"10","key":"5545_CR15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/neuonc\/nos335","volume":"15","author":"MA Mazurowski","year":"2013","unstructured":"Mazurowski MA, Desjardins A, Malof JM (2013) Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro Oncol 15(10):1389\u20131394","journal-title":"Neuro Oncol"},{"issue":"10","key":"5545_CR16","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/jnen\/nlaa101","volume":"79","author":"M Morris","year":"2020","unstructured":"Morris M, Driscoll M, Henson JW, Cobbs C, Jiang L, Gocke CD, Chen L, Rodriguez FJ (2020) Low-grade gemistocytic morphology in H3 G34R-mutant gliomas and concurrent K27M mutation: clinicopathologic findings. J Neuropathol Exp Neurol 79(10):1038\u20131043","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"5545_CR17","first-page":"vdab061","volume":"3","author":"T Picart","year":"2021","unstructured":"Picart T, Barritault M, Poncet D et al (2021) Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. Neurooncol Adv 3(1):vdab061","journal-title":"Neurooncol Adv"},{"issue":"5","key":"5545_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neurad.2018.02.006","volume":"45","author":"J Puntonet","year":"2018","unstructured":"Puntonet J, Dangouloff-Ros V, Saffroy R, Pag\u00e8s M, Andreiuolo F, Grill J, Puget S, Boddaert N, Varlet P (2018) Historadiological correlations in high-grade glioma with the histone 3.3 G34R mutation. J Neuroradiol 45(5):316\u2013322","journal-title":"J Neuroradiol"},{"key":"5545_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a014308","author":"MF Roussel","year":"2013","unstructured":"Roussel MF, Robinson GW (2013) Role of MYC in medulloblastoma. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a014308","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7384","key":"5545_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu X-Y et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226\u2013231","journal-title":"Nature"},{"issue":"5","key":"5545_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/bpa.12336","volume":"26","author":"DA Solomon","year":"2016","unstructured":"Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJJ, Perry A (2016) Diffuse midline gliomas with histone H3\u2013K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 26(5):569\u2013580","journal-title":"Brain Pathol"},{"issue":"4","key":"5545_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425\u2013437","journal-title":"Cancer Cell"},{"issue":"12","key":"5545_CR23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/RLU.0000000000002300","volume":"43","author":"FJ Vettermann","year":"2018","unstructured":"Vettermann FJ, Felsberg J, Reifenberger G et al (2018) Characterization of diffuse gliomas with histone H3\u2013G34 mutation by MRI and dynamic 18F-FET PET. Clin Nucl Med 43(12):895\u2013898","journal-title":"Clin Nucl Med"},{"issue":"2","key":"5545_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/neuonc\/nou130","volume":"17","author":"Y Wang","year":"2015","unstructured":"Wang Y, Qian T, You G et al (2015) Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro Oncol 17(2):282\u2013288","journal-title":"Neuro Oncol"},{"issue":"2","key":"5545_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/PAS.0000000000001781","volume":"46","author":"L Wang","year":"2022","unstructured":"Wang L, Shao L, Li H et al (2022) Histone H3.3 G34-mutant diffuse gliomas in adults. Am J Surg Pathol 46(2):249\u2013257","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"5545_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44(3):251\u2013253","journal-title":"Nat Genet"},{"issue":"3","key":"5545_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10014-017-0287-7","volume":"34","author":"K Yoshimoto","year":"2017","unstructured":"Yoshimoto K, Hatae R, Sangatsuda Y et al (2017) Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution. Brain Tumor Pathol 34(3):103\u2013112","journal-title":"Brain Tumor Pathol"},{"issue":"4","key":"5545_CR28","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.18632\/oncotarget.5456","volume":"7","author":"R-Q Zhang","year":"2016","unstructured":"Zhang R-Q, Shi Z, Chen H et al (2016) Biomarker-based prognostic stratification of young adult glioblastoma. Oncotarget 7(4):5030\u20135041","journal-title":"Oncotarget"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-023-05545-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-023-05545-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-023-05545-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T04:05:51Z","timestamp":1685333151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-023-05545-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["5545"],"URL":"https:\/\/doi.org\/10.1007\/s00701-023-05545-2","relation":{},"ISSN":["0942-0940"],"issn-type":[{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"7 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}